LiverSource »  Faculty »  Hepatology »  D. Montgomery Bissell, M.D.
 
Related Programs
Department of Surgery Websites

Make a Gift

A gift to the UCSF Department of Surgery can help physicians and scientist find treatments and cures for serious liver diseases such as hepatitis B & C, and liver cancer.

LiverSource »  Faculty »  Hepatology »  D. Montgomery Bissell, M.D.

D. Montgomery Bissell, M.D.

Professor of Medicine
Department of Medicine
Director Emeritus, UCSF Liver Center

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 476-2777
Fax: 415-476-0659
Montgomery.Bissell@ucsf.edu
Liver Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-1888

Gastroenterology and Liver Faculty Practice
350 Parnassus Ave., Suite 410
San Francisco, CA 94143
Phone: (415) 353-2318

Education

  • Harvard College, Cambridge, MA, A.B., 1962, English
  • Harvard Medical School, Boston, MA, M.D., 1967, Medicine

Residencies

  • Harvard Medical Service, Boston City Hospital, Residency training, 1967-70, Internal Medicine

Fellowships

Postdoctoral Training

  • University of California, San Francisco, Research training, 1970-73, Liver Biology

Board Certification

  • American Board of Internal Medicine

Program Affiliations

  • Member, UCSF Biomedical Sciences Graduate Program (BMS)
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Liver Center

Clinical Expertise

  • Alcoholic Liver Disease
  • Autoimmune Hepatitis
  • Benign Liver Tumors
  • Cirrhosis
  • Fulminant Hepatic Failure
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Live Donor Liver Transplantation
  • Liver Transplantation
  • Nonalcoholic Fatty Liver Disease
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis

Research Interests

  • Liver Injury and Repair

Biography

Dr. D. Montgomery Bissell is Professor of Medicine and Director Emeritus of the UCSF Liver Center, an NIH-funded consortium of 40 independently funded researchers who study the liver and its diseases. Bissell has a career-long interest in liver disease, dating to when he conducted a project on hepatocellular carcinoma in East Africa as a Harvard medical student. He then turned his attention to defining the cellular responses and molecular regulation of the scarring process known as fibrosis and cirrhosis. The latter is the most important consequence of many chronic liver diseases including inborn errors of metabolism, viral hepatitis, autoimmune states, alcohol abuse and others. It also is the setting for most cases of liver cancer.

Since 1981, Bissell has led the Rice-Liver Center Laboratory at San Francisco General Hospital, known internationally for basic research on fibrosis and defining new therapies to block fibrosis progression in patients. He is a member of several professional organizations including the American Society for Clinical Investigation and the Association of American Physicians and has served on numerous review panels for NIH, the Veterans Administration and other groups.

Research Summary

My laboratory investigates tissue remodeling in liver injury. We have been focusing recently on oval cells, which are liver progenitor cells and proliferate in several forms of liver injury. Oval cells, can be isolated and, with expansion in culture, hold promise for cell-based therapy of a variety of liver diseases. We have recently defined a member of the TNF-alpha family of cytokines that appears to be a specific growth factor for a subset of oval cells. We are interested also in mechanisms of the fibrotic response to biliary injury. We have found that TGFβ and the integrin αvβ6 have key roles.

Selected Publications

  1. Bissell DM. Therapy for hepatic fibrosis: Revisiting the preclinical models. Clin Res Hepatol Gastroenterol. 2011 Sep; 35(8-9):521-5.
  2. Bissell DM. Inflammation and hepatic fibrosis. Semin Liver Dis. 2010 Aug; 30(3):211-4.
  3. Bissell DM. Of mentors, mentoring, and extracellular matrix. Hepatology. 2009 Nov; 50(5):1330-8.
  4. Chang ML, Chen JC, Alonso CR, Kornblihtt AR, Bissell DM. Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver. Proc Natl Acad Sci USA 2004;101:18093-98.
  5. Kikuchi S, Griffin CT, Wang SS, Bissell DM. Role of cd44 in epithelial wound repair: migration of rat hepatic stellate cells utilizes hyaluronic acid and cd44v6. J Biol Chem 2005;280:15398-404.

X